128 related articles for article (PubMed ID: 487615)
1. Radiation-induced hyperprolactinaemia in a treated acromegalic.
Shalet SM; MacFarlane IA; Beardwell CG
Clin Endocrinol (Oxf); 1979; 11(2):169-71. PubMed ID: 487615
[TBL] [Abstract][Full Text] [Related]
2. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly.
Lamberts SW; Zweens M; Klijn JG; van Vroonhoven CC; Stefanko SZ; Del Pozo E
Clin Endocrinol (Oxf); 1986 Aug; 25(2):201-12. PubMed ID: 2878748
[TBL] [Abstract][Full Text] [Related]
3. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients.
van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464
[TBL] [Abstract][Full Text] [Related]
4. External irradiation of growth hormone producing pituitary adenomas: prolactin as a marker of hypothalamic and pituitary effects.
af Trampe EA; Lundell G; Lax I; Werner S
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):655-60. PubMed ID: 2004940
[TBL] [Abstract][Full Text] [Related]
5. Distinctive features of prolactin secretion in acromegalic patients with hyperprolactinaemia.
Serri O; Robert F; Comtois R; Jilwan N; Beauregard H; Hardy J; Somma M
Clin Endocrinol (Oxf); 1987 Oct; 27(4):429-36. PubMed ID: 3124991
[TBL] [Abstract][Full Text] [Related]
6. Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation.
Baldwin A; Cundy T; Butler J; Timmis AD
Acta Endocrinol (Copenh); 1985 Jan; 108(1):26-30. PubMed ID: 3969807
[TBL] [Abstract][Full Text] [Related]
7. Lack of rise in serum prolactin following yttrium-90 interstitial irradiation for acromegaly.
Clark AJ; Chahal P; Mashiter K; Joplin GF
Clin Endocrinol (Oxf); 1983 Nov; 19(5):557-63. PubMed ID: 6416717
[TBL] [Abstract][Full Text] [Related]
8. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
Cantalamessa L; Reschini E; Catania A; Giustina G
Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
[TBL] [Abstract][Full Text] [Related]
9. Low-dose pituitary irradiation for acromegaly.
Littley MD; Shalet SM; Swindell R; Beardwell CG; Sutton ML
Clin Endocrinol (Oxf); 1990 Feb; 32(2):261-70. PubMed ID: 2347088
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinaemia after external irradiation for acromegaly.
Clark AJ; Mashiter K; Goolden AW; Joplin GF
Clin Endocrinol (Oxf); 1982 Sep; 17(3):291-5. PubMed ID: 6131757
[No Abstract] [Full Text] [Related]
11. Long term effect of external pituitary irradiation on IGF1 levels in patients with acromegaly free of adjunctive treatment.
Mullan K; Sanabria C; Abram WP; McConnell EM; Courtney HC; Hunter SJ; McCance DR; Leslie H; Sheridan B; Atkinson AB
Eur J Endocrinol; 2009 Oct; 161(4):547-51. PubMed ID: 19661126
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation.
Werner S; af Trampe E; Palacios P; Lax I; Hall K
Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1713-20. PubMed ID: 4030438
[TBL] [Abstract][Full Text] [Related]
13. Hypopituitarism after external irradiation. Evidence for both hypothalamic and pituitary origin.
Samaan NA; Bakdash MM; Caderao JB; Cangir A; Jesse RH; Ballantyne AJ
Ann Intern Med; 1975 Dec; 83(6):771-7. PubMed ID: 812402
[TBL] [Abstract][Full Text] [Related]
14. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
[TBL] [Abstract][Full Text] [Related]
15. Prolactin- and other hormone-producing pituitary tumors: radiation therapy.
Noell KT
Clin Obstet Gynecol; 1980 Jun; 23(2):441-52. PubMed ID: 6994968
[No Abstract] [Full Text] [Related]
16. The treatment of acromegaly by transsphenoidal surgery.
Tucker HS; Grubb SR; Wigand JP; Watlington CO; Blackard WG; Becker DP
Arch Intern Med; 1980 Jun; 140(6):795-802. PubMed ID: 7387274
[TBL] [Abstract][Full Text] [Related]
17. Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation.
Ferrari C; Rampini P; Paracchi A; Boghen M; Mailland F
Eur J Clin Pharmacol; 1985; 27(6):707-11. PubMed ID: 3921384
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of radiotherapy for acromegaly on circulating prolactin.
Ciccarelli E; Corsello SM; Plowman PN; Jones AE; Touzel R; Rees LH; Besser GM; Wass JA
Acta Endocrinol (Copenh); 1989 Dec; 121(6):827-32. PubMed ID: 2609904
[TBL] [Abstract][Full Text] [Related]
19. How effective is external pituitary irradiation for growth hormone-secreting pituitary tumors?
Feek CM; McLelland J; Seth J; Toft AD; Irvine WJ; Padfield PL; Edwards CR
Clin Endocrinol (Oxf); 1984 Apr; 20(4):401-8. PubMed ID: 6713692
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.
Biermasz NR; van Dulken H; Roelfsema F
J Clin Endocrinol Metab; 2000 Jul; 85(7):2476-82. PubMed ID: 10902796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
